Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantinos P Imprialos

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Hypertension|September 16, 2015
Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?Konstantinos P Imprialos, Pantelis A Sarafidis, Asterios I Karagiannis
Current Hypertension Reports|April 21, 2022
Impact of Primary Aldosteronism in Resistant HypertensionKonstantinos Stavropoulos, Konstantinos P Imprialos, Dimitrios Patoulias, et al.
F1000Research|March 24, 2020
Recent advances in understanding and managing resistant/refractory hypertensionMichael Doumas, Konstantinos P Imprialos, Manolis S Kallistratos, et al.
Expert Review of Clinical Pharmacology|August 23, 2017
The effect of SGLT2 inhibitors on cardiovascular events and renal functionKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 30, 2016
Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?Konstantinos P Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos, et al.
Current Pharmaceutical Design|February 27, 2019
The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection FractionVasilios Papademetriou, Maria Toumpourleka, Konstantinos P Imprialos, et al.
Current Vascular Pharmacology|June 10, 2017
Sexual Dysfunction, Cardiovascular Risk and Effects of PharmacotherapyKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Expert Review of Gastroenterology & Hepatology|February 13, 2018
The potential role of statins in treating liver diseaseKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Current Pharmaceutical Design|March 9, 2019
Mineralocorticoid Receptor Antagonists in Essential and Resistant HypertensionKonstantinos P Imprialos, Sofia Bouloukou, Georgios Kerpiniotis, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 1, 2016
Current challenges in antihypertensive treatment in the elderlyKonstantinos P Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Hypertension|September 16, 2015
Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?Konstantinos P Imprialos, Pantelis A Sarafidis, Asterios I Karagiannis
Current Hypertension Reports|April 21, 2022
Impact of Primary Aldosteronism in Resistant HypertensionKonstantinos Stavropoulos, Konstantinos P Imprialos, Dimitrios Patoulias, et al.
F1000Research|March 24, 2020
Recent advances in understanding and managing resistant/refractory hypertensionMichael Doumas, Konstantinos P Imprialos, Manolis S Kallistratos, et al.
Expert Review of Clinical Pharmacology|August 23, 2017
The effect of SGLT2 inhibitors on cardiovascular events and renal functionKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 30, 2016
Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?Konstantinos P Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos, et al.
Current Pharmaceutical Design|February 27, 2019
The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection FractionVasilios Papademetriou, Maria Toumpourleka, Konstantinos P Imprialos, et al.
Current Vascular Pharmacology|June 10, 2017
Sexual Dysfunction, Cardiovascular Risk and Effects of PharmacotherapyKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Expert Review of Gastroenterology & Hepatology|February 13, 2018
The potential role of statins in treating liver diseaseKonstantinos P Imprialos, Konstantinos Stavropoulos, Michael Doumas, et al.
Current Pharmaceutical Design|March 9, 2019
Mineralocorticoid Receptor Antagonists in Essential and Resistant HypertensionKonstantinos P Imprialos, Sofia Bouloukou, Georgios Kerpiniotis, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 1, 2016
Current challenges in antihypertensive treatment in the elderlyKonstantinos P Imprialos, Chrysoula Boutari, Konstantinos Stavropoulos, et al.
Pageof 2